Atlas Trials

A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency

Clinical trial NCT03145831 · TERMINATED

Trial details

NCT number
NCT03145831
Sponsor
Versartis Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Growth Hormone Deficiency
Start date
2017-03-31
Primary completion
2017-11-30
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.